Clinical trial Recruiting at 1 site Interventional Ages 50 to 120

Mindfulness-based Cognitive Therapy versus a Health Enhancement Program for chronic pain and depression in older Black adults

Official title: Mindfulness-Based Cognitive Therapy Adapted for Older Adults At-Risk for the Chronic Pain-Depression Co-Morbidity; The Quiet Focus Pilot Randomized Controlled Trial

Run by Massachusetts General Hospital · NCT07118722 · Data updated 2026-11-12

This pilot will see if Quiet Focus, a culturally adapted mindfulness-based cognitive therapy program, helps older Black adults with long-term pain and mild-to-moderate depression more than a general health program.

Quick facts

Study typeInterventional
Ages50 Years to 120 Years
SexAll
Enrollment60 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJanuary 15, 2027
Study endsJune 30, 2027
Registry record updatedAugust 25, 2026
Trial IDNCT07118722 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-fluent adults age 50 or older who identify with Black racial/ethnic groups, have chronic musculoskeletal pain (NRS >4 for >3 months) and mild-to-moderate depressive symptoms (PHQ-9 score 5–14), and can attend in-person or video sessions without recent changes in antidepressant dosing.

Probably not a fit

Patients with moderately severe or severe depression (PHQ-9 ≥15), current substance dependence, significant cognitive impairment, active psychosis, extensive prior CBT or mindfulness training, or inability to participate in person or by video are unlikely to benefit from this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized pilot compares Quiet Focus, an adaptation of mindfulness-based cognitive therapy (MBCT) tailored for older Black adults, to a Health Enhancement Program (a structurally matched active control). The trial enrolls community-dwelling adults age 50 and older with chronic musculoskeletal pain and mild-to-moderate depressive symptoms and uses in-person and video-delivered sessions. Primary aims are to establish feasibility, acceptability, and credibility of the adapted MBCT and to collect preliminary data on pain interference and quality of life outcomes. Findings will be used to design a later fully powered randomized controlled trial.

Why it matters

Potential benefit: If successful, Quiet Focus could improve quality of life and reduce pain-related interference and depressive symptoms in older Black adults using a culturally tailored, non-drug approach.

How similar studies have gone: MBCT has demonstrated benefit for depressive symptoms and some chronic pain outcomes in prior trials, but culturally adapted MBCT specifically for older Black adults is largely novel and not well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participant Inclusion Criteria

1. Older adult (age ≥ 50)
2. All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
3. Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months
4. Depressed (PHQ-9 score of 5-14)
5. English fluency/literacy
6. Ability and willingness to participate via in-person and video
7. No change to type or dose of antidepressant medications for at least 6 weeks prior to screening
8. Willing to provide informed consent and comply with all aspects of the protocol

Participant Exclusion Criteria

1. Moderately severe or severe depressive symptoms (PHQ-9 ≥ 15)
2. Current substance abuse/dependence
3. Significant cognitive impairment
4. History of more than 8 sessions of cognitive-behavioral therapy
5. History of previous training in mindfulness or undergoing counseling more than once a month
6. History of or current diagnosis of psychosis
7. Active suicidal ideation (PHQ-9 item #9 or otherwise reported during screening) or self-harm within the past 90 days
8. Current participation in another behavioral clinical trial

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.